Bio-Rad Laboratories Inc. a global leader of life science research and clinical diagnostic products today announced the launch of its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit a sensitive accurate and cost-effective tool used to detect SARS-CoV-2 in a communitys wastewater.With wastewater testing becoming more widely adopted this assay provides the ability for a community to determine if the virus is present days to weeks before the virus may be detected in individuals said Simon May Bio-Rad Senior Vice President Digital Biology Group. As we continue to manage the spread of COVID-19 it is especially important to have a highly sensitive early warning system that can be implemented on a community-wide basis he said.ddPCR technology is recommended in the Centers for Disease Control and Prevention guidelines CDC for wastewater testing and use of the technology has been published by the Environmental Protection Agency EPA as a dependable method to quantify viruses in wastewater.The PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit includes all reagents needed to detect the virus in wastewater along with software for automated analysis. The test runs on Bio-Rads QX200 Droplet Digital PCR System QX200 AutoDG Droplet Digital PCR System and the QX ONE Droplet Digital PCR System. It joins Bio-Rads menu of COVID-19 products that are being used in the global fight against COVID-19. Other products include molecular qPCR and ddPCR instruments and assays antibody tests quality controls and ddPCR assays to detect SARS-CoV-2 variants of concern.
🔍 Key Information
📄
Tender Reference No.
463326965
📅
Publication Date
24 Jun 2021
🌐
Sector
Water and Sanitation
📝
Notice Type
News
📍
Location
United states
📁
Documents & Downloads
No documents found
🏷️ CPV
No CPV found
Need help with this bid?
Our bid experts can help you find, evaluate & win more tenders.